The Role of Topical Moxifloxacin, a New Antibacterial in Europe, in the Treatment of Bacterial Conjunctivitis

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.31, Iss.8, 2011-08, pp. : 543-557

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topical Lomefloxacin versus Topical Chloramphenicol in the Treatment of Acute Bacterial Conjunctivitis

By Agius-Fernandez A.

Clinical Drug Investigation, Vol. 15, Iss. 4, 1998-04 ,pp. : 263-269

Adis International

Access to resources Recommend Favorite

Moxifloxacin 0.5% Ophthalmic Solution: In Bacterial Conjunctivitis

By Keating Gillian M.

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 89-99

Adis International

Access to resources Recommend Favorite

Moxifloxacin (Bay 12-8039):a new methoxy quinolone antibacterial

By MacGowan A.P.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 2, 1999-02 ,pp. : 181-199

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic evaluation of topical calcineurin inhibitors for treatment of allergic conjunctivitis

By Wan Xiao Chloe Dimov Vesselin

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 4, 2014-04 ,pp. : 543-549

Informa Healthcare

Access to resources Recommend Favorite

The Role of Topical Retinoids in the Treatment of Photoaging

By Stratigos Alexander J. Katsambas Andreas D.

Drugs, Vol. 65, Iss. 8, 2005-01 ,pp. : 1061-1072

Adis International

Access to resources Recommend Favorite